CRISPR toolmaker Synthego raises $110M Series C led by Peter Thiel’s VC fund
The financing, led by Thiel's Founders Fund, will help the company expand its reach into Europe and Asia while building up its manufacturing capabilities.
FDA probe looks into unauthorized herpes vaccine research
The criminal investigation examines research by a Southern Illinois University professor who injected people with his unauthorized herpes vaccine.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
An offshore clinical trial for herpes vaccine tests new regulatory landscape
Neither the Food and Drug Administration nor a safety panel known as an institutional review board, or an “IRB,” monitored the testing of a vaccine its creators say prevents herpes outbreaks.
Breakout Labs backs antibacterials, genomics and biosensor tattoos
From California to Boston to NYC, four more life science startups have been accepted into the Thiel Foundation's Breakout Labs, a philanthropic incubator for seed-stage companies.
Morning Read: Peter Thiel-backed Auris Surgical Robots acquires Hansen Medical for $80M
Also, Medtronic recalls nearly 10,000 battery backs for patient breathing monitors over heat damage risk and Alere loses half a billion dollars in value as investors fear Abbott's acquisition will fall through.
Peter Thiel-backed carrier screening upstart Counsyl lays off 27 employees
Counsyl's layoffs are in sales support, marketing, design and engineering.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Peter Thiel firm Mithril Capital Management raises $600M
Sources say the Peter Thiel-backed firm is oversubscribed for this fund, and it may reach $1 billion before it closes.
Peter Thiel-backed ‘unicorn’ biotech posits that stem cells are root cause of cancer
Stem CentRx posits that cancer is caused by stem cells gone awry - and is developing antibody drug conjugate therapies to help attack cancer at its root. The Peter Thiel-backed "unicorn" startup is valued at some $3 billion.
Peter Thiel has turned to biotech, specifically focused on anti-aging
Co-founder of PayPal and initial investor in Facebook, Peter Thiel knows where to put his money and has an eye for what will be successful – that much is clear. But now, his eye has drifted over to the biotech world, and once again, the money is rolling in. According to MIT Technology Review, Thiel […]
Peter Thiel’s ‘futuristic’ Breakout Labs funds three new life sciences startups
The Peter Thiel-backed Breakout Labs just funded three new life sciences startups: Neumitra, E3X Bio and Ion Dx – with platforms in the wearables, diagnostics and high-throughput screening spaces. They’re all prototypical Breakout Labs companies – super early stage, but showcasing an ambition and vision that shies away from playing it safe. “We’re after companies that have deep, […]
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Weed aficionado Snoop Dogg creating fund to invest in cannabis tech startups
Calvin Broadus, Jr. (a.k.a. Snoop Dogg, a.k.a. Snoop Lion) is no stranger to the cannabis lifestyle, and now that some states are legalizing medical and recreational marijuana use, there’s no better time for the rapper to invest and actually make money instead of just smoking it. Sources told TechCrunch that Snoop is putting together a […]
Breakout Labs backs startups building wearable for the gut, stem cell treatment for bones
A wearable device that could transform how physicians diagnose the underlying causes of GI disorders is one of three innovative early stage life science companies Peter Thiel’s Breakout Labs is backing. The program from the Thiel Foundation provides up to $350,000 for companies to reach certain milestones critical to their development, according to a company […]